Human S100B/NEF/S100 ORF/cDNA clone-Adenovirus particle (BC001766)
Cat. No.: vGMAP000204
Pre-made Human S100B/NEF/S100 Adenovirus for S100B overexpression in-vitro and in-vivo. The S100B adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified S100B-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.
At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.
Go to
S100B/S100 Beta/S100B/NEF products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Adenovirus Grade | Adenovirus quantity |
| vGMAP000204 | Human S100B Adenovirus particle | Research Grade-In vitro | 1E+10PFU (1E+10pfu/ml×1ml) |
| 5E+10PFU (1E+10pfu/ml×5ml) | |||
| 1E+11PFU (1E+10pfu/ml×10ml) | |||
| Research Grade-In vivo | 1E+11PFU (1E+11pfu/ml×1ml) | ||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMAP000204 |
| Gene Name | S100B |
| Accession Number | BC001766 |
| Gene ID | 6285 |
| Species | Human |
| Product Type | Adenovirus particle (overexpression) |
| Insert Length | 279 bp |
| Gene Alias | NEF,S100,S100beta |
| Fluorescent Reporter | GFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Kanamycin |
| ORF Nucleotide Sequence | ATGTCTGAGCTGGAGAAGGCCATGGTGGCCCTCATCGACGTTTTCCACCAATATTCTGGAAGGGAGGGAGACAAGCACAAGCTGAAGAAATCCGAACTCAAGGAGCTCATCAACAATGAGCTTTCCCATTTCTTAGAGGAAATCAAAGAGCAGGAGGTTGTGGACAAAGTCATGGAAACACTGGACAATGATGGAGACGGCGAATGTGACTTCCAGGAATTCATGGCCTTTGTTGCCATGGTTACTACTGCCTGCCACGAGTTCTTTGAACATGAGTGA |
| ORF Protein Sequence | MSELEKAMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDNDGDGECDFQEFMAFVAMVTTACHEFFEHE |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T87206-Ab | Anti-S100B monoclonal antibody |
| Target Antigen | GM-Tg-g-T87206-Ag | S100B protein |
| ORF Viral Vector | pGMAP000204 | Human S100B Adenovirus plasmid |
| ORF Viral Vector | vGMAP000204 | Human S100B Adenovirus particle |
Target information
| Target ID | GM-T87206 |
| Target Name | S100B/S100 Beta |
|
Gene Group Identifier (Target Gene ID in Homo species) |
6285 |
| Gene ID |
100054841 (Equus caballus), 101099488 (Felis catus), 20203 (Mus musculus), 25742 (Rattus norvegicus) 491615 (Canis lupus familiaris), 525716 (Bos taurus), 6285 (Homo sapiens), 708117 (Macaca mulatta) |
| Gene Symbols & Synonyms | S100B,S100b,Bpb,S100P,NEF,S100,S100-B,S100beta |
| Target Alternative Names | Bpb,NEF,Protein S100-B,S-100 protein beta chain,S-100 protein subunit beta,S100,S100 Beta,S100 calcium-binding protein B,S100-B,S100B,S100P,S100b,S100beta |
| Uniprot Accession |
P02638,P04271,P04631,P50114
Additional SwissProt Accessions: P50114,P04631,P02638,P04271 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | Therapeutics Target, Diagnostics Biomarker |
| Disease | cancer, Prostate Cancer, Diffuse traumatic brain injury, Hypoxic ischemic encephalopathy [HIE] |
| Disease from KEGG | |
| Gene Ensembl | ENSECAG00000012395, ENSMUSG00000033208, ENSCAFG00845027676, ENSBTAG00000004777, ENSG00000160307, ENSMMUG00000063077 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


